# Vibliome Therapeutics, Inc. — Form D

Vibliome Therapeutics, Inc. of BOZEMAN, MT, a company, filed a Form D exempt-offering notice with the SEC on 2018-04-12. The offering totals $1.0M, of which $113K was reported sold. Industry: Other.

## Offering

- Filed: 2018-04-12
- Form: D
- Accession: 0001735831-18-000003
- Industry: Other
- Exemptions: 06b
- Total offering: $1.0M
- Amount sold: $113K
- Remaining: $887K
- Investors: 3
- Date of first sale: 2018-01-05
- Revenue range: Decline to Disclose
- SEC file number: 021-310035

## Issuer

- Name: Vibliome Therapeutics, Inc.
- CIK: 0001735831
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 533 E. MENDENHALL STREET, BOZEMAN, MT, 59715
- Phone: 1-406-599-7987

## Officers, directors & promoters (7)

| Name | Role | Location |
| --- | --- | --- |
| GARY FLYNN | Director | BOZEMAN, MT |
| ROBERT GOODWIN | Director | BOZEMAN, MT |
| GARY FLYNN | Executive Officer | BOZEMAN, MT |
| ROBERT GOODWIN | Executive Officer | BOZEMAN, MT |
| JAMES LINFIELD | Executive Officer | BOZEMAN, MT |
| GARY FLYNN | Promoter | BOZEMAN, MT |
| ROBERT GOODWIN | Promoter | BOZEMAN, MT |

## More

- [CIK 1735831 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1735831&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001735831-18-000003.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.